Download this datacard
Overview
Lobbying Costs
17,500€
Financial year: Jul 2019 - Jun 2020
Lobbyists (Full time equivalent)
1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Seqirus
EU Transparency Register
205355142651-14 First registered on 06 May 2021
Goals / Remit
At Seqirus, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza vaccines help protect millions of people. We find solutions to big, complex, challenging problems, and we see the results in the world around us. Then we do it all over again the following year. Seqirus is one of the largest influenza vaccine companies. We were created when our parent company, CSL Limited, acquired the Novartis influenza vaccine business and combined it with vaccine subsidiary, bioCSL.
Main EU files targeted
EU Health Data Space
EU Health Emergency Response Authority
EU Pharmaceutical legislation
EU Emergency Authorisation Regulation
ECDC and EMAAddress
Head Office
Seqirus
Level 3, 8AA, 29 Market St
Maidenhead SL6 8AD
UNITED KINGDOM -
People
Total lobbyists declared
1
Employment time Lobbyists 100% 1 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Vaccines Europe
European Federation of Pharmaceutical Associations (EFPIA)Member organisations
None declared
-
Financial Data
Closed financial year
Jul 2019 - Jun 2020
Lobbying costs for closed financial year
17,500€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
As members of the trade association Vaccines Europe we have conducted an EU Flu Day in 2020 and plan to do so again in 2021
European Parliament hosted workshop presenting research on public perceptions of flu post Covid pandemic - September 2021Other activities
None declared
- Meetings
Meetings
None declared
- Meetings